Chih Kang Ke
Direktor/Vorstandsmitglied bei TAHO PHARMACEUTICALS LTD
Aktive Positionen von Chih Kang Ke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TAHO PHARMACEUTICALS LTD | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Chih Kang Ke
Ehemalige bekannte Positionen von Chih Kang Ke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EASYWELL BIOMEDICALS, INC. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
| MACHVISION INC. | Direktor/Vorstandsmitglied | 08.06.2010 | - |
| Independent Dir/Board Member | 08.06.2010 | - | |
| PHARMADAX INC. | Direktor/Vorstandsmitglied | - | - |
| Global Strategic Investment Management, Inc. | Vorstandsvorsitzender | - | - |
| Director of Investments | - | - | |
| Private Equity Investor | - | - |
Statistik
International
| Taiwan | 6 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Finance | 2 |
| Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MACHVISION INC. | Producer Manufacturing |
| EASYWELL BIOMEDICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Global Strategic Investment Management, Inc. | Finance |
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
TAHO Pharmaceuticals Ltd.
 TAHO Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
- Börse
- Insiders
- Chih Kang Ke
- Erfahrung
